Does KETOPROFEN Cause Hepatic cytolysis? 83 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Hepatic cytolysis have been filed in association with KETOPROFEN (Orudis). This represents 1.5% of all adverse event reports for KETOPROFEN.
83
Reports of Hepatic cytolysis with KETOPROFEN
1.5%
of all KETOPROFEN reports
0
Deaths
34
Hospitalizations
How Dangerous Is Hepatic cytolysis From KETOPROFEN?
Of the 83 reports, 34 (41.0%) required hospitalization, and 5 (6.0%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KETOPROFEN. However, 83 reports have been filed with the FAERS database.
What Other Side Effects Does KETOPROFEN Cause?
Pain (595)
Headache (574)
Hypersensitivity (556)
Erythema (546)
Acute kidney injury (517)
Hyperhidrosis (516)
Hepatic enzyme increased (508)
Asthma (507)
Rheumatoid arthritis (493)
Immunodeficiency (492)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which KETOPROFEN Alternatives Have Lower Hepatic cytolysis Risk?
KETOPROFEN vs KETOPROFEN LYSINE
KETOPROFEN vs KETOROLAC TROMETHAMINE
KETOPROFEN vs KETOROLAC\KETOROLAC TROMETHAMINE
KETOPROFEN vs KETOTIFEN
KETOPROFEN vs KLONOPIN